All News

We cancer survivors are complicated — not more complicated than others who have faced their mortality head-on, but there’s a certain bucket we get put in when we let others know about our diagnoses.

Chemotherapy affected my brain in ways that I was never told about.

Patients with cancer should keep a healthy heart during cancer treatment by exercising regularly and eating healthy, an expert emphasized.

In 2023, my goal is to continue building my role as a patient advocate and to support other cancer survivors in the fight through the various organizations I am involved with.

The addition of Tecentriq to platinum-based chemotherapy/gemcitabine did not boost outcomes in patients with metastatic bladder cancer, according to results from the IMvigor 140 trial.

The addition of Cabometyx to Opdivo and Yervoy improved outcomes for patients with advanced kidney cancer, according to recent research.

Researchers identified several biomarkers that may indicate how a patient responds to Padcev, a type of antibody drug conjugate for patients with urothelial carcinoma, a type of bladder cancer.

When I was undergoing cancer treatment, writing was a creative outlet that helped calm my nerves.

The combination demonstrated survival benefit in patients with metastatic hormone-sensitive prostate cancer, regardless of risk or volume of disease.

Cancer often brings with it bad news, including expensive bills, but one day, a surprise came – one I’ll never forget.

From Senator Bob Casey undergoing prostate cancer surgery to a man giving away his Superbowl tickets to a good friend with stage 4 cancer, here’s what is happening in the oncology space this week.

The administration of Pluvicto within six months of radium-223 treatment proved to be safe and efficacious in patients with metastatic castration-resistant prostate cancer, research showed.

Patients treated with Nubeqa were less likely to develop disease metastasis or discontinue treatment 6 to 18 months after ARI course start compared to Xtandi or Erleada, according to data presented at ASCO GU.

Carvykti and other drugs prove that there are still options for patients whose myeloma got worse on prior therapies.

Cancer brought me a forced transformation and gave me better a perspective on life.

Teri Griege completed an Ironman triathlon in 2009, and less than a month later received a stage 4 colorectal cancer diagnosis. In this episode of Cancer Horizons, she shared her story.

Surprisingly, there were many reasons to be happy, even throughout my difficult cancer treatments, and I have some awesome memories.

When my wife was going through breast cancer treatment, I started drawing with my non-dominant hand as a means of distraction and self-care.

The Food and Drug Administration agreed to speed up the review of avasopasem to treat severe oral mucositis in patients with head and neck cancer.

I was optimistic about my lymphoma diagnosis and new treatment plan when a lump was found after I underwent a mammogram.

Cancer robbed our family of more time with my husband. In the years since his death, this is what I’ve learned on grieving, life, dating and the fear of letting go.

Combining maveropepimut-S plus Keytruda showed promising outcomes in a small group of patients with diffuse large B-cell lymphoma, study results showed.

Cancer treatments including chemotherapy and radiation may increase a patient’s risk for heart disease, and being mindful of some of the symptoms may be one of the steps for prevention, one expert said.

After meeting a woman who was forced to wait five months between finding a lump and being diagnosed with breast cancer, I wondered if that time affected the stage of her disease.

In honor of Valentine’s Day, we asked our audience to share some love for someone who helped them through their cancer experience. Here’s what they had to say.

The hold has been placed due to visual side effects in a number of patients with solid tumors.

The PRESERVE 1 trial was discontinued due to responses and survival measures favoring placebo versus Cosela when added to a chemoimmunotherapy regimen.